Discover 3,601 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,601
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
for
NSCLC Stage IV
Location: Fountain Valley CA, El Segundo CA, Fullerton CA,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase 3, Recruiting
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Location: Orange CA, Houston TX, Birmingham AL, Louisville KY,
Sponsor: Octapharma
Sex: All
Age: 2 - 17
Code: NCT04929236
Phase 3, Recruiting
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
for
Chickenpox
Location: Huntington Park CA, West Covina CA, National City CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06693895
Phase 3, Recruiting
The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement
for
Dementia
Location: Los Angeles CA
Sponsor: Healthy Minds Initiative
Sex: All
Age: 55 - 70+
Code: NCT06741865
Recruiting
A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)
for
Erythropoietic Protoporphyria (EPP),
Location: Huntington Beach CA, Cincinnati OH
Sponsor: Portal Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT07820085
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Huntington Beach CA, Fountain Valley CA, Los Angeles CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase 3, Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for
Chronic Idiopathic Constipation (CIC)
Location: Inglewood CA, Santa Ana CA, Canoga Park CA,
Sponsor: Ardelyx
Sex: All
Age: 18 - 70+
Code: NCT07382167
Phase 3, Recruiting
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
for
Severe Asthma
Location: Inglewood CA, West Covina CA, Lancaster CA,
Sponsor: Generate Biomedicines
Sex: All
Age: 12 - 70+
Code: NCT07359846
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: Inglewood CA, Los Angeles CA, Irvine CA, Pomona CA,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase 3, Recruiting
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
for
Chemotherapy-induced Nausea and Vomiting
Location: Anaheim CA, Chandler AZ, Billings MT, Hattiesburg MS,
Sponsor: Xiamen LP Pharmaceutical Co., Ltd
Sex: All
Age: 18+
Code: NCT05199818
Phase 3, Recruiting
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Location: Anaheim CA, Albuquerque NM, Abilene TX,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06801834
Phase 3, Recruiting
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
for
Cholangiocarcinoma
Location: Los Angeles CA, Houston TX, Milwaukee WI, Chicago IL,
Sponsor: Genfit
Sex: All
Age: 18+
Code: NCT05874414
Phase 1, Phase 2, Recruiting
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
for
Prostate Cancer,
Location: Anaheim CA, Santa Rosa CA, Albuquerque NM, Tacoma WA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: Male
Age: 18+
Code: NCT04729114
Phase 1, Recruiting
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
for
Breast Cancer
Location: Anaheim CA, Palo Alto CA, Pierre SD, Mitchell SD,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07405801
Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Fountain Valley CA, Santa Monica CA, Los Angeles CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
for
Depressive Disorder, Major
Location: Anaheim CA, Glendale CA, Colton CA, Redlands CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT06559306
Phase 3, Recruiting
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
for
Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung
Location: Fountain Valley CA, Beverly Hills CA, Dallas TX,
Sponsor: Lantern Pharma Inc.
Sex: All
Age: 18+
Code: NCT05456256
Phase 2, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Fountain Valley CA, Whittier CA, Los Angeles CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Fountain Valley CA, Irvine CA, San Diego CA,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase 2, Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Relapsed Diffuse Large B-cell Lymphoma,
Location: Fountain Valley CA, Santa Fe NM, Omaha NE, Saskatoon,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)